Who is sponsoring NCT06901115?

NCT06901115 is sponsored by Menoufia University.

What drugs are being tested in NCT06901115?

Interventions in NCT06901115: Nesbit technique, Corkscrew technique.

What condition does NCT06901115 study?

NCT06901115 studies TURP(Transurethral Resection of Prostate), BPH (Benign Prostatic Hyperplasia), Prostate.

Is NCT06901115 still recruiting?

NCT06901115 is currently completed. Last updated 21 May 2025.

Last reviewed 2025-05-21 · How we verify

NCT06901115

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Corkscrew Technique: A Novel Modification in Transurethral Resection of Large Prostate (60-100 g) Optimizing Resection Efficacy and Safety: A Double-blind Randomized Controlled Trial

Completed NA Last updated 21 May 2025

What this trial tests

NA trial testing Nesbit technique in TURP(Transurethral Resection of Prostate) in 90 participants. Completed in 28 April 2025.

Timeline

1 November 2024

Primary endpoint
1 April 2025

28 April 2025

Quick facts

Lead sponsor	Menoufia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	1 November 2024
Primary completion	1 April 2025
Estimated completion	28 April 2025
Sites	1 location across Egypt

Drugs / interventions tested

Nesbit technique
Corkscrew technique

Conditions studied

TURP(Transurethral Resection of Prostate) — all drugs for TURP(Transurethral Resection of Prostate) →
BPH (Benign Prostatic Hyperplasia) — all drugs for BPH (Benign Prostatic Hyperplasia) →
Prostate — all drugs for Prostate →

Sponsor

Menoufia University

Who can join

Eligibility, male only, with TURP(Transurethral Resection of Prostate) or BPH (Benign Prostatic Hyperplasia). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transurethral resection of the prostate (TURP) is still the gold standard for surgical management of enlarged prostate. However, many techniques and minimally invasive procedures are now in the comparative track with Bipolar resection as Laser enucleation. Multiple drawbacks of Classic TURP problems related to large prostate management as the retreatment after Bipolar resection, another issue that prolonged operative time, Loss of orientation during resection due to rotation of one of the 2 kissing lobe, Bleeding of the 1st lobe resection side make the 2nd lobe resection harder and lengthier, Median lobe resection or bladder neck resection is done at last to avoid sub-trigonal injury. however, due to median lobe obstruction, irrigation is poor during all the resection. length of learning curve, the modification of early median lobe resection carry the risk of sub-trigonal injury. So, this study is a trial to analyze the effect of new technique in resection of large prostate with good orientation and less time of operation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Menoufia University trials

Trials by the same sponsor.

NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06901115 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia University
Last refreshed: 21 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06901115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing